- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 21.11.24 | Catheter Precision, Inc. - S-1, General form for registration of securities | - | SEC Filings | ||
| 14.11.24 | Catheter Precision, Inc. Announces Initial LockeT Purchase From Montefiore Medical Center | 283 | ACCESSWIRE | FORT MILL, SC / ACCESSWIRE / November 14, 2024 / Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced... ► Artikel lesen | |
| 13.11.24 | Ra Medical Systems reports Q3 results | 4 | Seeking Alpha | ||
| 13.11.24 | Catheter Precision, Inc. Announces Third Quarter Update and Financial Results | 167 | ACCESSWIRE | FORT MILL, SC / ACCESSWIRE / November 13, 2024 / Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced... ► Artikel lesen | |
| 04.11.24 | Catheter Precision, Inc. Announces New Clinical Data Presented at SCRN | 201 | ACCESSWIRE | FORT MILL, SC / ACCESSWIRE / November 4, 2024 / Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company, today announced that new clinical data from the VIVO EU... ► Artikel lesen | |
| 25.10.24 | Catheter Precision announces exercise of warrants for $4.9M of gross proceeds | 1 | Seeking Alpha | ||
| 25.10.24 | Catheter Precision, Inc. Announces Exercise of Warrants for $4.9 Million of Gross Proceeds | 339 | ACCESSWIRE | FORT MILL, SC / ACCESSWIRE / October 25, 2024 / Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company, today announced the entry into a definitive agreement for... ► Artikel lesen | |
| CATHETER PRECISION Aktie jetzt für 0€ handeln | |||||
| 25.10.24 | Catheter Precision, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 23.10.24 | Catheter Precision, Inc: Catheter Precision to Attend Society for Cardiac Robotic Navigation With New Clinical Data Presented on October 28 - 29 | 154 | ACCESSWIRE | FORT MILL, SC / ACCESSWIRE / October 23, 2024 / Catheter Precision, Inc. (NYSE American:VTAK), a US based innovative medical device company focused on electrophysiology products announced that there... ► Artikel lesen | |
| 21.10.24 | Catheter Precision, Inc: Catheter Precision Announces Clinical Publication of Non-Invasive Stereotactic Radioablation Using VIVO | 231 | ACCESSWIRE | FORT MILL, SC / ACCESSWIRE / October 21, 2024 / Catheter Precision, Inc. (NYSE American:VTAK), a US based medical device company focused on developing technologically advanced products for the cardiac... ► Artikel lesen | |
| 15.10.24 | Catheter Precision, Inc: Catheter Precision to Attend the International Symposium on Catheter Ablation Techniques | 310 | ACCESSWIRE | FORT MILL, SC / ACCESSWIRE / October 15, 2024 / Catheter Precision, Inc. (NYSE/American:VTAK), a US based medical device company focused on developing technologically advanced products for the cardiac... ► Artikel lesen | |
| 10.10.24 | Catheter Precision, Inc: Catheter Precision Scheduled to Attend the International Ventricular Tachycardia Symposium October 11 - 12 in New York City | 397 | ACCESSWIRE | FORT MILL, SC / ACCESSWIRE / October 10, 2024 / Catheter Precision, Inc. (NYSE/American:VTAK), a US based medical device company focused on developing technologically advanced products for the cardiac... ► Artikel lesen | |
| 02.10.24 | Catheter Precision, Inc: Catheter Precision Continues to Expand Clinical Data and Acceptance of VIVO | 299 | ACCESSWIRE | FORT MILL, SC / ACCESSWIRE / October 2, 2024 / Catheter Precision, Inc. (NYSE/American:VTAK), a company dedicated in the development and marketing of technologically advanced products for the cardiac... ► Artikel lesen | |
| 01.10.24 | VTAK stock touches 52-week low at $0.36 amid market challenges | 1 | Investing.com | ||
| 24.09.24 | Catheter Precision, Inc. Receives Chinese Patent for LockeT | 264 | ACCESSWIRE | FORT MILL, SC / ACCESSWIRE / September 24, 2024 / Catheter Precision, Inc. (VTAK:NYSE/American), a company engaged in the development and marketing of technologically advanced products for the cardiac... ► Artikel lesen | |
| 18.09.24 | Catheter Precision, Inc. Expands LockeT Distribution to Middle East | 319 | ACCESSWIRE | FORT MILL, SC / ACCESSWIRE / September 18, 2024 / Catheter Precision, Inc. (the"Company") (NYSE American:VTAK), a US based medical device pioneering electrophysiology products, announced that it has... ► Artikel lesen | |
| 11.09.24 | Catheter Precision gets purchase order for LockeT | 2 | Seeking Alpha | ||
| 11.09.24 | Catheter Precision, Inc. Reports First Purchase Order for LockeT in the Pacific Northwest Territory | 284 | ACCESSWIRE | FORT MILL, SC / ACCESSWIRE / September 11, 2024 / Catheter Precision, Inc. (NYSE American:VTAK), a US based innovative medical device company in the growing field of cardiac electrophysiology, announced... ► Artikel lesen | |
| 06.09.24 | Catheter Precision, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 06.09.24 | VTAK stock touches 52-week low at $0.4 amid market challenges | 1 | Investing.com |
Seite:
1 2 3 4 Weiter >>
65 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 47,500 | +4,86 % | Eckert & Ziegler Aktie: Vielversprechende Perspektiven in Sicht! | Die Eckert & Ziegler Aktie zeigt sich zu Jahresbeginn 2025 mit einem Kurs von 43,20 EUR weitgehend stabil. Der Berliner Spezialist für radioaktive Komponenten konnte im vergangenen Jahr eine positive... ► Artikel lesen | |
| DRAEGERWERK | 46,100 | +0,22 % | HAUCK AUFHÄUSER INVESTMENT BANKING stuft Draegerwerk auf 'Positiv' | HAMBURG (dpa-AFX Analyser) - Hauck Aufhäuser Investment Banking hat die Einstufung für Drägerwerk auf "Buy" mit einem Kursziel von 70 Euro belassen. Das Papier zählt zu den Favoriten des Hauses für... ► Artikel lesen | |
| BICO GROUP | 2,892 | +3,43 % | BRISANTE Meldung setzt Bico Group Aktionäre unter Zugzwang. Bitte reagieren Sie jetzt sofort! | ||
| SERNOVA | 0,168 | +3,96 % | Sernova Aktie: Streitigkeiten verschärfen Krise! | Die kanadische Biotechnologiefirma Sernova Corp. steht vor bedeutenden Herausforderungen, wie aus dem am 23. Dezember 2024 veröffentlichten Jahresbericht hervorgeht. Der Wirtschaftsprüfer hat dabei... ► Artikel lesen | |
| GERATHERM MEDICAL | 3,480 | -3,33 % | Geratherm Medical Aktie: Keine Überraschungen erwartet | Die Geratherm Medical AG verzeichnete in den vergangenen Tagen einen beachtlichen Kursanstieg von 28 Prozent. Der aktuelle Aktienkurs liegt bei 3,79 EUR (Stand: 14. Dezember 2024). Diese Entwicklung... ► Artikel lesen | |
| CARDINAL HEALTH | 115,15 | -0,04 % | Dividendenbekanntmachungen (02.01.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABM INDUSTRIES INC US0009571003 0,265 USD 0,2559 EUR AECOM US00766T1007 0,26 USD 0,251 EUR AIR PRODUCTS & CHEMICALS INC US0091581068 1... ► Artikel lesen | |
| RESMED | 224,30 | -0,93 % | Minimales Kursplus bei der ResMed-Aktie (222,3049 €) | Im US-amerikanischen Wertpapierhandel ist der Anteilsschein von ResMed zur Stunde unauffällig. Das Papier kostete zuletzt 230,09 US-Dollar. Der heutige Börsentag brachte bislang wenig Kursbewegung bei... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,951 | +2,48 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Applauds U.S. Surgeon General's Advisory Highlighting Alcohol as a Leading Preventable Cause of Breast Cancer | ||
| HENRY SCHEIN | 68,78 | -0,46 % | Henry Schein upgraded at BoA as headwinds subside | ||
| UNIDOC HEALTH | 0,338 | +3,05 % | UniDoc Health Corp. blickt zurück auf ein Jahr des Wachstums und der Innovation | - Strategische Partnerschaften und KI-Integration positionieren UniDoc als E-Health-Lösung
VANCOUVER, British Columbia, 17. Dezember 2024 / IRW-Press / UniDoc Health Corp.... ► Artikel lesen | |
| ZIMMER BIOMET | 99,86 | +0,14 % | Dividendenbekanntmachungen (30.12.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABACUS GROUP UTS AU0000291882 0,0212 AUD 0,0126 EUR ABRDN EMERGING MARKETS EQUITY INCOME FUN ... US00301W1053 0,1 USD 0,0959 EUR AMCON... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,520 | 0,00 % | Sonoma Pharmaceuticals, Inc. - 8-K, Current Report | ||
| CO-DIAGNOSTICS | 0,985 | +2,60 % | Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results | SALT LAKE CITY, Nov. 7, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development... ► Artikel lesen | |
| CYTOSORBENTS | 0,950 | -4,62 % | CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue | Fourth quarter product revenue growth estimated at 22% to 25% year-over-year Fourth quarter gross margin estimated to improve to approximately 70% Management will host in-person investor... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 0,964 | +5,59 % | Tempest Therapeutics: Tempest Receives Orphan Drug Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma (HCC) | BRISBANE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeutics... ► Artikel lesen |
CATHETER PRECISION INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,550 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CATHETER PRECISION INC finden Sie auf Wallstreet Online.
